Ascendis Pharma A (ASND) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Ascendis Pharma A (ASND) over the last 14 years, with Q4 2025 value amounting to -$717.2 million.
- Ascendis Pharma A's Enterprise Value fell 1994.21% to -$717.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$717.2 million, marking a year-over-year decrease of 1994.21%. This contributed to the annual value of -$696.2 million for FY2025, which is 1643.42% down from last year.
- As of Q4 2025, Ascendis Pharma A's Enterprise Value stood at -$717.2 million, which was down 1994.21% from -$630.2 million recorded in Q3 2025.
- Ascendis Pharma A's Enterprise Value's 5-year high stood at -$278.6 million during Q2 2024, with a 5-year trough of -$849.4 million in Q1 2022.
- Moreover, its 5-year median value for Enterprise Value was -$552.0 million (2025), whereas its average is -$564.7 million.
- Per our database at Business Quant, Ascendis Pharma A's Enterprise Value soared by 4035.83% in 2023 and then plummeted by 10074.2% in 2025.
- Ascendis Pharma A's Enterprise Value (Quarter) stood at -$515.7 million in 2021, then increased by 8.65% to -$471.1 million in 2022, then grew by 8.77% to -$429.8 million in 2023, then plummeted by 39.13% to -$597.9 million in 2024, then fell by 19.94% to -$717.2 million in 2025.
- Its last three reported values are -$717.2 million in Q4 2025, -$630.2 million for Q3 2025, and -$559.2 million during Q2 2025.